Exploring biological basis of Syndrome differentiation in coronary heart disease patients with two distinct Syndromes by integrated multi-omics and network pharmacology strategy

被引:23
|
作者
Wu, Gaosong [1 ]
Zhao, Jing [1 ,2 ]
Song, Nixue [3 ,4 ,5 ]
Zheng, Ningning [1 ]
Zeng, Yuanyuan [2 ]
Yao, Tingting [2 ]
Zhang, Jingfang [2 ]
Weng, Jieqiong [2 ]
Yuan, Mengfei [2 ]
Zhou, Hu [3 ,4 ,5 ]
Shen, Xiaoxu [2 ]
Li, Houkai [1 ]
Zhang, Weidong [1 ,6 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Integrat Med Res, 1200 Cai Lun Rd, Shanghai 201203, Peoples R China
[2] Beijing Univ Chinese Med, Dongzhimen Hosp, 5 Haiyuncang, Beijing 100700, Peoples R China
[3] Chinese Acad Sci, Shanghai Inst Mat Med, Dept Analyt Chem, Shanghai 201203, Peoples R China
[4] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China
[5] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
[6] Second Mil Med Univ, Sch Pharm, Dept Phytochem, 325 Guo He Rd, Shanghai 200433, Peoples R China
基金
中国国家自然科学基金;
关键词
Coronary heart disease; Syndrome differentiation; Traditional Chinese Medicine; Proteomics; Metabolomics; Network pharmacology; TRADITIONAL CHINESE MEDICINE; APOLIPOPROTEIN-E; CHOLESTEROL; METABOLISM; EXPRESSION; CLEARANCE; RECEPTOR; GENES;
D O I
10.1186/s13020-021-00521-3
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background Traditional Chinese Medicine (TCM) is distinguished by Syndrome differentiation, which prescribes various formulae for different Syndromes of same disease. This study aims to investigate the underlying mechanism. Methods Using a strategy which integrated proteomics, metabolomics study for clinic samples and network pharmacology for six classic TCM formulae, we systemically explored the biological basis of TCM Syndrome differentiation for two typical Syndromes of CHD: Cold Congealing and Qi Stagnation (CCQS), and Qi Stagnation and Blood Stasis (QSBS). Results Our study revealed that CHD patients with CCQS Syndrome were characterized with alteration in pantothenate and CoA biosynthesis, while more extensively altered pathways including D-glutamine and D-glutamate metabolism; alanine, aspartate and glutamate metabolism, and glyoxylate and dicarboxylate metabolism, were present in QSBS patients. Furthermore, our results suggested that the down-expressed PON1 and ADIPOQ might be potential biomarkers for CCQS Syndrome, while the down-expressed APOE and APOA1 for QSBS Syndrome in CHD patients. In addition, network pharmacology and integrated analysis indicated possible comorbidity differences between the two Syndromes, that is, CCQS or QSBS Syndrome was strongly linked to diabetes or ischemic stroke, respectively, which is consistent with the complication disparity between the enrolled patients with two different Syndromes. These results confirmed our assumption that the molecules and biological processes regulated by the Syndrome-specific formulae could be associated with dysfunctional objects caused by the Syndrome of the disease. Conclusion This study provided evidence-based strategy for exploring the biological basis of Syndrome differentiation in TCM, which sheds light on the translation of TCM theory in the practice of precision medicine.
引用
收藏
页数:21
相关论文
共 6 条
  • [1] Exploring biological basis of Syndrome differentiation in coronary heart disease patients with two distinct Syndromes by integrated multi-omics and network pharmacology strategy
    Gaosong Wu
    Jing Zhao
    Jing Zhao
    Nixue Song
    Ningning Zheng
    Yuanyuan Zeng
    Tingting Yao
    Jingfang Zhang
    Jieqiong Weng
    Mengfei Yuan
    Hu Zhou
    Xiaoxu Shen
    Houkai Li
    Weidong Zhang
    Chinese Medicine, 16
  • [2] Exploring the "gene-protein-metabolite" network of coronary heart disease with phlegm and blood stasis syndrome by integrated multi-omics strategy
    Yang, Guang
    Zhou, Siyuan
    He, Haoqiang
    Shen, Zinuo
    Liu, Yongmei
    Hu, Jun
    Wang, Jie
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [3] Integrated network pharmacology, mass cytometry and multi-omics analysis the effect of Jingfang granule on intestinal immune disorder in mice with cold-dampness syndrome
    Li, Shirong
    Liu, Mingfei
    Pan, Lihong
    Feng, Qun
    Lu, Xiaoyan
    Yao, Jingchun
    Xiao, Xuefeng
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2025, 255
  • [4] Exploring mechanisms of Chaihu-Shugan-San against liver fibrosis by integrated multi-omics and network pharmacology approach
    Xie, Zhihao
    Xie, Zhiying
    Trujillo, Nicolas Pineda
    Yang, Ting
    Yang, Chunxia
    BIOSCIENCE REPORTS, 2022, 42 (07)
  • [5] A network pharmacology integrated pharmacokinetics strategy for uncovering pharmacological mechanism of compounds absorbed into the blood of Dan-Lou tablet on coronary heart disease
    Ding, Mingya
    Ma, Wenfang
    Wang, Xiaoyan
    Chen, Shujing
    Zou, Shuhan
    Wei, Jinna
    Yang, Yuqiao
    Li, Jin
    Yan, Xuejing
    Wang, Hui
    Li, Yuhong
    Wang, Qilong
    Mao, Haoping
    Gao, Xiu-mei
    Chang, Yan-xu
    JOURNAL OF ETHNOPHARMACOLOGY, 2019, 242
  • [6] Using integrated GC-MS analysis, in vitro experiments, network pharmacology: exploring migao fatty oil active components/mechanisms against coronary heart disease
    Jian, Lina
    Guo, Jiangtao
    Zhang, Yongping
    Liu, Jie
    Liu, Yao
    Xu, Jian
    FOOD SCIENCE AND TECHNOLOGY, 2022, 42